Author:
Becker Kristian C.,Kwee Lydia Coulter,Neely Megan L.,Grass Elizabeth,Jakubowski Joseph A.,Fox Keith A. A.,White Harvey D.,Gregory Simon G.,Gurbel Paul A.,Carvalho Leonardo de Pinto,Becker Richard C.,Magnus Ohman E.,Roe Matthew T.,Shah Svati H.,Chan Mark Y.
Abstract
AbstractChanges in platelet physiology are associated with simultaneous changes in microRNA concentrations, suggesting a role for microRNA in platelet regulation. Here we investigated potential associations between microRNA and platelet reactivity (PR), a marker of platelet function, in two cohorts following a non-ST elevation acute coronary syndrome (NSTE-ACS) event. First, non-targeted microRNA concentrations and PR were compared in a case (N = 77) control (N = 76) cohort within the larger TRILOGY-ACS trial. MicroRNA significant in this analysis plus CVD-associated microRNAs from the literature were then quantified by targeted rt-PCR in the complete TRILOGY-ACS cohort (N = 878) and compared with matched PR samples. Finally, microRNA significant in the non-targeted & targeted analyses were verified in an independent post NSTE-ACS cohort (N = 96). From the non-targeted analysis, 14 microRNAs were associated with PR (Fold Change: 0.91–1.27, p-value: 0.004–0.05). From the targeted analysis, five microRNAs were associated with PR (Beta: −0.09–0.22, p-value: 0.004–0.05). Of the 19 significant microRNAs, three, miR-15b-5p, miR-93 and miR-126, were consistently associated with PR in the TRILOGY-ACS and independent Singapore post-ACS cohorts, suggesting the measurement of circulating microRNA concentrations may report on dynamic changes in platelet biology following a cardiovascular ischemic event.
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Bray, P.F., Platelet reactivity and genetics down on the pharm. Trans Am Clin Climatol Assoc 117: p. 103-11; discussion 111-2, (2006).
2. Camaioni, C. et al. Microparticles and microRNAs: new players in the complex field of coagulation. Intern Emerg Med 8(4), 291–6 (2013).
3. Go, A. S. et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 129(3), e28–e292 (2014).
4. Roffi, M. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3), 267–315 (2016).
5. Angiolillo, D. J. et al. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 50(16), 1541–7 (2007).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献